Momenta Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference

CAMBRIDGE, Mass., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard P. Shea, Chief Financial Officer, will deliver a corporate presentation at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3rd, at 9:40 am EST. The conference will be held at The Waldorf Astoria Hotel in New York City.

A live audio webcast of the presentation will be available on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately three hours after the event and will be available through February 2nd, 2010.

About Momenta

Momenta Pharmaceuticals is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

CONTACT:  Momenta Pharmaceuticals, Inc.
          Investor Relations
          Beverly Holley
          617-395-5189